H-1B sponsorship profile: NovaRock Biotherapeutics Ltd. Across U.S. Department of Labor LCA disclosures, NovaRock Biotherapeutics Ltd filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (6 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on NovaRock Biotherapeutics Ltd’s H-1B petitions range from $69,875 at the low end to $94,552 at the high end, with a petition-weighted average of $84,037. That range reflects the mix of occupations the company sponsors, led by Senior Scientist (2 petitions at $94,552 avg), followed by Scientist II and Associate Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. NovaRock Biotherapeutics Ltd is headquartered in Ewing, NJ under NAICS code 541714, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where NovaRock Biotherapeutics Ltd ranks. By H-1B petition volume, NovaRock Biotherapeutics Ltd is #23,486 of 119,880 employers nationally and #1,770 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.